Elm City Bioscience Center welcomes
three leases - 40,000 s/f

New Haven, CT XingImaging, LLC (a Mitro company), Revalia Bio, Inc., and General Biological Corporation, have selected Elm City Bioscience Center at 55 Church St. for their new locations. Occupying a total of nearly 40,000 s/f, these three companies will join the Bioscience Center’s community of leading innovators, which already includes Modifi Biosciences, Alphina Therapeutics, BioMed X, and Yale XR Pediatrics, bringing the total of occupied laboratories in the building to 50,000 s/f. 

XingImaging, LLC, a leader in biomarker imaging, will utilize a total area of 24,066 s/f on three floors for its laboratory, clinic, and headquarters for the US operations and support to its rest-of-world business offerings. “We are thrilled to be moving to the Elm City Bioscience Center building, being in the heart of the city will serve our research participants, our team members and the overall growth and success of our company,” said Gilles Tamagnan, Mitro, CEO. The company specializes in radiotracer production and clinical imaging research to evaluate and support the development, testing and advancement of treatments for neurodegenerative disorders, oncology, and other disease pathologies. Working in collaboration with many biotech and pharmaceutical companies, XingImaging offers end to end support of radiopharmaceutical imaging trials. 

Revalia Bio, Inc. was founded on the deeply held belief that organ donation holds the key to revolutionizing biomedical innovation. A trailblazer in organ perfusion research, Revalia Bio’s technology allows them to honor the gift of every donated organ by accelerating the development of major medical breakthroughs. Revalia Bio aims to utilize its new facility consisting of 8,019 s/f at Elm City Bioscience Center to unleash the full potential of organ perfusion towards unlocking the future of personalized medicine. “We are thrilled to be joining such a vibrant community of scientists and innovators at the Elm City Bioscience Center,” said Greg Tietjen, founder and CEO of Revalia Bio.

General Biological Corporation engineers and develops technologies to catalyze a shift from traditional chemical manufacturing to sustainable bioproduction. The company’s commitment to supplant petrochemistry positions it as a key player in the future of industrial advancements. Their new 6,145 s/f space and the collaborative environment of Elm City Bioscience Center is the ideal setting for General Biological to accelerate its research and development efforts. 

“Our goal has been to create a collaborative environment for scientific discovery and innovation. With the addition of XingImaging, Revalia Bio and General Biological to our existing companies, we now have the critical mass to achieve that goal.” said David Goldblum, Hurley Group president. 

“Having so many scientists pursuing cutting-edge research under one roof right in the center of downtown is another big step towards putting New Haven on the map as a major destination for pharma research and biotech companies.”

As these new tenants embark on their journey at Elm City Bioscience Center, they join a distinguished group of companies and researchers dedicated to pushing the boundaries of science and technology. Elm City Bioscience Center looks forward to supporting their groundbreaking work and witnessing the positive impact they will have on society and the broader scientific community.